SCHEMBL5863737

SCHEMBL5863737

Cc1cc(C)c(S(=O)(=O)N(Cc2cccc(O)c2)c2ccc(C=CC(=O)O)cc2)c(C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.41
GPR55 Q9Y2T6 1/20 0.41
KEAP1 Q14145 5/20 0.40
NFE2L2 Q16236 2/20 0.40
ALDH1A1 P00352 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
AKR1C4 P17516 1/20 0.38
AKR1C1 Q04828 1/20 0.38
AKR1C2 P52895 1/20 0.38
PTGES O14684 1/20 0.38
ESR1 P03372 2/20 0.37
STAT5B P51692 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5863735 1.00 AKR1C3 (0.41) AKR1C3GPR55KEAP1NFE2L2ALDH1A1
SCHEMBL5864173 0.89 NR1H4 (0.48) GPR55KEAP1CA12CA1CA4
SCHEMBL5864174 0.89 NR1H4 (0.48) GPR55KEAP1CA12CA1CA4
SCHEMBL5864062 0.86 MAPT (0.43) KEAP1ALDH1A1LMNAMAPT
SCHEMBL5864066 0.86 MAPT (0.43) KEAP1ALDH1A1LMNAMAPT
SCHEMBL5863833 0.86 GPR55 (0.42) GPR55KEAP1NFE2L2ALDH1A1PTGES
SCHEMBL5863828 0.86 GPR55 (0.42) GPR55KEAP1NFE2L2ALDH1A1PTGES
SCHEMBL5864472 0.85 TDP1 (0.47) GPR55ALDH1A1LMNA
SCHEMBL5864468 0.85 TDP1 (0.47) GPR55ALDH1A1LMNA
SCHEMBL5864476 0.85 TDP1 (0.47) GPR55ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053212-B2 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC. (US) 2006-05-30 US disclosed
EP-1542967-A1 AMIDE AND SULFONAMIDE LIGANDS FOR THE ESTROGEN RECEPTOR Pfizer Products Inc. (US) 2005-06-22 EP disclosed
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC 2004-06-10 US disclosed
WO-2004026823-A1 AMIDE AND SULFONAMIDE LIGANDS FOR THE ESTROGEN RECEPTOR PFIZER PRODUCTS INC. (US) 2004-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor GHSR, GPER1, SSTR1 AKR1C3 415/4885GPR55 109/4885KEAP1 4082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.